last | Philochem

Giulio Casi – presented “Arming disease-targeting ligands with cytokines and cytotoxic drugs” at World ADC Conference. Frankfurt (DE), 24th-25th February.

by last | Feb 24, 2015 | 2015, Press Releases

Dario Neri – presented “Immunocytokines for the Therapy of Cancer and of Chronic Inflammation” at Biochemical Pharmacology Discussion Group (NY Academy Sciences/Boehringer). NY (USA), 27th January.

by last | Jan 27, 2015 | 2015, Press Releases

Philogen announced Option and License Agreement with Pfizer Inc.

by last | Dec 22, 2014 | 2014, Press Releases, Scientific

Philogen announced Option and License Agreement with Pfizer Inc. to develop and commercialize multiple antibody drug conjugates and targeted nano particles. (see full press release). Siena (Italy), December 22nd, 2014.

Dario Neri – presented ‘Immunocytokines for the therapy of cancer and of chronic inflammation’ at Antibody Engineering and Therapeutics conference

by last | Dec 7, 2014 | 2014, Press Releases, Scientific

Dario Neri – presented ‘Immunocytokines for the therapy of cancer and of chronic inflammation’ at Antibody Engineering and Therapeutics conference. Huntingdon Beach, California (USA), December 7th-11th, 2014.

Giulio Casi – presented “Arming disease-targeting ligands with cytokines and cytotoxic drugs” at World ADC Conference. Frankfurt (DE), 24th-25th February.

Dario Neri – presented “Immunocytokines for the Therapy of Cancer and of Chronic Inflammation” at Biochemical Pharmacology Discussion Group (NY Academy Sciences/Boehringer). NY (USA), 27th January.

Philogen announced Option and License Agreement with Pfizer Inc.

Dario Neri – presented ‘Immunocytokines for the therapy of cancer and of chronic inflammation’ at Antibody Engineering and Therapeutics conference

Recent Posts